Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Challenges in the treatment of cystic fibrosis in the era of CFTR modulatorsAuthors' replyUse of elexacaftor+tezacaftor+ivacaftor in individuals with cystic fibrosis and at least one F508del allele a systematic review and meta-analysisDiscontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY) results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsAssessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor.
Schmidt CJ, Moura LS, Dalcin PTR, Ziegler B. Schmidt CJ, et al. Among authors: dalcin ptr. J Bras Pneumol. 2024 May 27;50(2):e20240107. doi: 10.36416/1806-3756/e20240107. J Bras Pneumol. 2024. PMID: 38808835 Free PMC article. No abstract available.
Impact of impaired pulmonary function on clinical outcomes in survivors of severe COVID-19 without pre-existing respiratory disease.
Benedetto IG, Silva RMCD, Hetzel GM, Viana GDS, Guimarães AR, Folador L, Brentano VB, Garcia TS, Ribeiro SP, Dalcin PTR, Gazzana MB, Berton DC. Benedetto IG, et al. Among authors: dalcin ptr. J Bras Pneumol. 2023 May 26;49(3):e20220452. doi: 10.36416/1806-3756/e20220452. eCollection 2023. J Bras Pneumol. 2023. PMID: 37255163 Free PMC article.
Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association).
Athanazio RA, Tanni SE, Ferreira J, Dalcin PTR, Fuccio MB, Esposito C, Canan MGM, Coelho LS, Firmida MC, Almeida MB, Marostica PJC, Monte LFV, Souza EL, Pinto LA, Rached SZ, Oliveira VSB, Riedi CA, Silva Filho LVRFD. Athanazio RA, et al. Among authors: dalcin ptr. J Bras Pneumol. 2023 May 15;49(2):e20230040. doi: 10.36416/1806-3756/e20230040. eCollection 2023. J Bras Pneumol. 2023. PMID: 37194817 Free PMC article.
Clinical characteristics and outcomes of incident cases of COVID-19 in unvaccinated adult cystic fibrosis patients in southern Brazil: a prospective cohort study conducted during the first year of the COVID-19 pandemic.
Camargo CC, Jacobsen LB, Wilsmann J, Silveira MN, Ziegler B, Rossi EP, Oliveira CT, Dalcin PTR. Camargo CC, et al. Among authors: dalcin ptr. J Bras Pneumol. 2022 Nov 28;48(6):e20220265. doi: 10.36416/1806-3756/e20220265. eCollection 2022. J Bras Pneumol. 2022. PMID: 36449821 Free PMC article.
33 results